Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Nao Mogi"'
Autor:
Hiroyuki Takei, Keisuke Arai, Akiko Iriuchijima, Yuko Seki, Yoshito Tsushima, Takayuki Suto, Nao Mogi, Hidenori Otake, Keigo Endo, Junpei Nakamura, Kazuma Yarita
Publikováno v:
The Kitakanto Medical Journal. 71:15-18
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c34197ab69505f0c2763ee4e5eec7e92
https://doi.org/10.2974/kmj.71.15
https://doi.org/10.2974/kmj.71.15
Autor:
Yasuyuki Takahashi, Xieyi Zhang, Takao Kanzaki, Nao Mogi, Takayuki Suto, Tetsuya Higuchi, Yoshito Tsushima
Publikováno v:
Journal of Nuclear Medicine Technology. 48:326-330
The number of patients with the extremely rare disease gastroenteropancreatic (GEP) neuroendocrine tumor (NET) has increased rapidly in recent years. 111In-pentetreotide SPECT in somatostatin receptor scintigraphy has been used for the assessment of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::05b7fdc2e34f4aa8eb7f2771dd660b43
https://doi.org/10.2967/jnmt.120.249680
https://doi.org/10.2967/jnmt.120.249680
Autor:
Takao, Kanzaki, Yasuyuki, Takahashi, Tetsuya, Higuchi, Xieyi, Zhang, Nao, Mogi, Takayuki, Suto, Yoshito, Tsushima
Publikováno v:
Journal of nuclear medicine technology. 48(4)
The number of patients with the extremely rare disease gastroenteropancreatic (GEP) neuroendocrine tumor (NET) has increased rapidly in recent years.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::c1ba29dd0d0b46a88fefe1dc143c8491
https://pubmed.ncbi.nlm.nih.gov/32887762
https://pubmed.ncbi.nlm.nih.gov/32887762
Autor:
Takao Kanzaki, Yasuyuki Takahashi, Tetsuya Higuchi, Xieyi Zhang, Nao Mogi, Takayuki Suto, Yoshito Tsushima
Publikováno v:
Journal of Nuclear Medicine Technology; Dec2020, Vol. 48 Issue 4, p1-30, 30p
Autor:
Makoto Sakai, Ryosuke Okada, Yoshiki Kubota, Yusuke Itabashi, Nao Mogi, Yasuhiro Fukushima, Takashi Nakano, Tatsuya Ohno, Takayuki Sutou
Publikováno v:
Nihon Hoshasen Gijutsu Gakkai zasshi. 72(12)
Purpose The contrast agent used in the diagnostic department has high atomic numbers and might influence dose deposition in the particle therapy. In particular, the influence of gadolinium-based (Gd) contrast agent on range in carbon ion radiotherapy
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9956357ed32356deb9d39a882cd80deb
https://pubmed.ncbi.nlm.nih.gov/28003610
https://pubmed.ncbi.nlm.nih.gov/28003610
Autor:
Takao Kanzaki, Yasuyuki Takahashi, Tetsuya Higuchi, Xieyi Zhang, Nao Mogi, Takayuki Suto, Yoshito Tsushima, Kanzaki, Takao, Takahashi, Yasuyuki, Higuchi, Tetsuya, Zhang, Xieyi, Mogi, Nao, Suto, Takayuki, Tsushima, Yoshito
Publikováno v:
Journal of Nuclear Medicine Technology; Sep2020, Vol. 48 Issue 3, p1-30, 30p